Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Sitavig (acyclovir Lauriad, Sitavir) (BA-021)
print preview
bookmark
share with colleague
General Information
Company
BioAlliance Pharma S.A.
Description
Mucoadhesive formulation of acyclovir
Molecular Target
Mechanism of Action
Antiviral agent
Latest Stage of Development
Approved
Indication
Herpes simplex virus (HSV)
Partner
Teva Pharmaceutical Industries Ltd.
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy